Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Kevin Judice Net Worth & Insider Trades

Kevin Judice - CEO, Dice Therapeutics, Inc

As of August 9, 2023

What is Kevin Judice's Net Worth?

The current estimated net worth of Dice Therapeutics, Inc's CEO, Kevin Judice, is estimated to be about $23.22M . Kevin Judice owns about 799,685 units of Dice Therapeutics, Inc common stock. In the last 2 years at Dice Therapeutics, Inc, Kevin Judice has sold an estimated value of $499.98K worth.

What is Kevin Judice's Past Insider Trading?

Kevin Judice's largest sale order was 13,698 units , worth over $499.98K on May 5, 2023. In total, Kevin Judice has made about 5 transactions over 2 years of their time at Dice Therapeutics, Inc. Kevin Judice usually trades in September, August, January, April and May, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kevin Judice

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Kevin Judice's' Mailing Address?

  • Mailing address is 6310 Nancy Ridge Drive San Diego CA 92121 CA

What are Dice Therapeutics, Inc's Past Insider Trades?

Dice Therapeutics, Inc's most recent insider trade came on June 23, 2023 by Northpond Ventures GP Llc, Northpond Ventures Lp, Northpond Ventures GP Ii Llc, Northpond Ventures Ii Lp and Michael Rubin who sold 2,492,871 units worth $115.92M . In the last 2 years, insiders at Dice Therapeutics, Inc have sold an estimated value of $122.13M and bought an estimated value of $116.01M worth of shares. Insider trading is most common in August, with the busiest year in 2023. The most active traders at the company are James P. Scopa, Director,  John R Jacobsen, CSO,  and Peter Kolchinsky .

DICE Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...